Bigfoot Biomedical

Healthcare giant Abbott (NYSE: ABT) has announced an agreement to purchase Bigfoot Biomedical, a company specializing in insulin management systems. The transaction is expected to be completed this month, subject to the fulfillment of customary conditions. Financial details of the acquisition were not disclosed. History of Collaboration and Continued PartnershipAbbott…